INTRODUCTION
AMP deaminase (AMPD; EC 3.5.4.6) is a highly regulated enzyme involved in purine nucleotide catabolism and interconversion (i.e. AMP + H20 -. IMP + NH3). Multiple isoforms, each exhibiting unique patterns of tissue distribution and kinetic, immunologic and chromatographic properties, can be isolated from rat [1, 2] and human [3, 4] tissues. In humans, four homotetrameric variants have been described, including isoforms M (muscle), L (liver) and the El and E2 (erythrocyte) isoforms. Most tissues and cells express more than one AMPD isoform [1] [2] [3] [4] and evidence has been presented suggesting that in addition to homotetramers, heterotetramers also exist that form among individual isoform-specific subunits [5] .
Molecular studies indicate that mammalian AMPDs are encoded by transcripts produced from a multigene family. In humans, the AMPD1 gene is specific for isoform M [6] , the AMPD2 gene for isoform L [7] and the AMPD3 gene for the E isoforms [8] . Alignments among predicted amino acid sequences across the human AMPD multigene family show that the Cterminal region is conserved whereas the N-terminal region is divergent [7, 8] . Alternative transcripts are produced from the human AMPD1 [9] and AMPD3 [8] genes, each containing different sequences at, or near, their 5'-ends. In most cases, alternative AMPD transcripts are predicted to confer N-terminal variation on their respective isoform, contributing to the complexity of AMPD expression.
A single report, describing the cloning, sequencing and bacsequence near the 5'-end of the published AMPD2 cDNA, which affects the predicted N-terminal amino acid sequence of isoform L; (2) alternative transcripts resulting from exon shuffling at, or near, the 5'-end of the AMPD2 gene that exhibit tissue-specific patterns of relative abundance; (3) predicted usage of three different initiation codons to confer variable N-terminal extensions on isoform L polypeptides; and (4) an extension of a 3' untranslated sequence in some AMPD2 transcripts. In addition, reverse transcriptase PCR and additional RNase protection analyses were used to map the 5'-ends of two mutually-exclusive exon 1 sequences, both of which contain multiple transcriptioninitiation sites. These results are discussed in relation to predicted isoform L diversity across human tissues and cells.
terial expression of AMPD2 cDNA, represents currently available knowledge of this human gene [7] . Prokaryotic expression of AMPD2 cDNA generates isoform L activity. Northern blot analysis of multiple human tissues indicates that the AMPD2 transcript is approximately 4 kb in size, significantly larger than the reported 3.3 kb cDNA sequence. The presence of a poly(A)+ tail on the 3'-most extending AMPD2 cDNA (HuPl 1OB/16) infers that the 5'-end of this sequence is most likely missing. In addition, a slightly smaller and more abundant AMPD2 transcript is observed predominantly, if not exclusively, in brain. This study was designed to identify missing AMPD2 cDNA sequences and to address the molecular basis for production of multiple transcripts. To accomplish these goals, a human cerebellum (HuCe) cDNA library was screened using a previously described human insert comprising most of the available 5' AMPD2 cDNA sequence (HuT 6A). The results of this study correct and extend previous information regarding the AMPD2 cDNA sequence and show regulated expression of multiple AMPD2 transcripts, similar to other members of this multigene family. Filters were hybridized at relatively high stringency (0.6 M NaCl and 67°C) using an [a-32P]dCTP-labelled insert of a previously described human AMPD2 cDNA, HuT 6A [7] . Overnight exposure of the washed filters yielded 16 duplicate positives, and 11 were plaque-purified in subsequent rounds of screening. Following EcoRl restriction endonuclease digestion of isolated phage DNA, recombinant inserts were gel-purified and subcloned into the polylinker region ofplasmid Bluescribe (pBS; Stratagene Cloning Systems, La Jolla, CA, U.S.A.). Both strands of all recombinant plasmid cDNAs were sequenced by the dideoxy chain-termination method [10] [7] demonstrate that all are AMPD2 cDNAs; their relative sizes and locations are illustrated in Figure 1 . As expected, each overlaps the HuT 6A insert used as the probe for screening the library. Five are either completely contained within the probe sequence or extend only in the 3' direction. Of these, four do not contribute any new information, i.e., two (HuCe 9B and lOB) are identical and extend only 638 bp from the 3'-end of the probe sequence, and two (HuCe 6B and 8) are contained entirely within the area covered by the probe, except for some anomalous sequences at their 5'-ends, as judged by alignments with other AMPD2 cDNA and genomic clones (results not shown). However, the fifth clone (HuCe 1) is nearly 3 kb in length and extends 85 bp beyond the 3'-end of the previously published AMPD2 cDNA sequence (see below).
EXPERIMENTAL
The other six newly isolated AMPD2 cDNAs (HuCe 3B, 6A, 7A, 7B, 1OA and 11) all extend 5' to the HuT 6A sequence. Significantly, all diverge from the published AMPD2 cDNA sequence beginning at the nucleotide + 27/ + 28 boundary ( Figure 2 ). Moreover, five (HuCe 6A excluded) contain the published nucleotide sequence -175 to -181 immediately adjacent to nucleotide + 28. Further inspection of the published AMPD2 nucleotide sequence from -174 to + 27 shows GT and AG dinucleotides at the 5'-and 3'-boundaries respectively (see Figure 2 and [7] Figure 2) . Each has 538 bp of identical sequence to their 5'-
+3178
ends, which all terminate in an EcoRl restriction endonuclease site (GAATTC). This EcoRl site appears to be included in the AMPD2 sequence, as judged by the absence of an adjacent linker sequence, i.e. GC, found in all other clones isolated from this library. The presence of an endogenous EcoRl restriction endonuclease site in these three cDNA sequences suggested the possibility of an additional 5'-end sequence in the original phage insert. Therefore, more phage DNA was prepared from each of these three isolates and an additional 75 bp EcoRl fragment was subsequently recovered from one, HuCe lOA, the 5'-end of which contains the appropriate linker sequence. The HuCe 6A clone, which is missing the putative 131 bp exon immediately upstream of nucleotide + 28, does contain a 29 bp sequence at its 5'-end that is identical with the 3'-end of the 538 bp stretch in clones 3B, 7B and IOA (see Figure 2 ). HuCe 6A also contains four downstream intervening sequences (see Figure  1) , information that will be presented in a separate manuscript detailing the structure of the entire human AMPD2 gene.
The combined sequence data obtained from these six HuCe isolates suggests that multiple transcripts are produced from the human AMPD2 gene. Figure 2 shows that the sequence 3' to the nucleotide + 27/ + 28 boundary is found in all AMPD2 cDNA clones. Conversely, the 131 bp sequence immediately upstream of nucleotide + 28 in five of six HuCe cDNA clones appears to represent an exon subject to an alternative splicing event that can remove it from some mature AMPD2 transcripts (as evidenced by the HuCe 6A clone). Finally, the two divergent sequences at the extreme 5'-ends of all six HuCe cDNAs exhibit a mutually exclusive pattern of inclusion in these clones and appear to represent two additional upstream exons in the AMPD2 gene.
Figure 1 Schematic illustration of HuCe AMP02 cDNAs
Insert sizes are relative to the upper horizontal axis, which is in bp. Where possible, the 5'-and 3'-end of each cDNA is numbered according to the previously published AMPD2 cDNA sequence [7] , which is denoted by a black bar (U). Sequences extending 3 + 28 continue to align upstream for another 124 bp, at which point additional divergence is observed (see Figure 2 ). These observations indicate that the 131 bp sequence immediately upstream of nucleotide + 28 comprises an exon (boxed sequences in Figure 2 ). Furthermore, absence of the 131 bp sequence from the sixth clone, Huce 6A, suggests that this putative exon is subject to an alternative splicing event which can remove it from some mature AMPD2 transcripts.
Additional upstream nucleotide sequence divergence is observed immediately adjacent to the putative 131 bp exon. Two of the HuCe cDNA clones, 7A and 11, contain 160 bp of identical sequence up to a point near the 5'-end of the former (see Figure   2 ). The HuCe 7A clone then has an additional sequence at its 5'-Isolation and partial characterization of AMPD2 genomic DNA In order to validate the above hypotheses and clarify ambiguities derived from sequence analysis of the newly isolated cDNAs, it was necessary to examine AMPD2 genomic DNA. This was accomplished using subclones from two AMPD2 clones, RPMIIs and RPMI-9, previously isolated from a human genomic library [7] . The significance of the extended 3' sequence found in the HuCe 1 cDNA was addressed first by isolating a 6 kb Sphl fragment from the RPMI-ls clone that begins in intron 10 (results not shown) and extends beyond the 3'-end of the gene. Exon 18 is co-linear with the previously published cDNA sequence and contains the 3'-end ofthe AMPD2 coding sequence, the predicted translation termination codon, T(U)GA, and the entire 895 bp 3' untranslated region of the gene ( Figure 3 ). Previously defined by the 3'-end of the HuPI IOB/16 cDNA clone, the 3' untranslated region extends to nucleotide +3178, twelve base pairs downstream from a consensus poly(A)+ signal (aataaa) and adjacent to the poly(A)+ tail in the HuPI IOB/16 cDNA clone ( Figure 3 ). However, an alignment between the newly isolated HuCe 1 cDNA and the AMPD2 genomic DNA sequence demonstrates nucleotide identity extending 85 bp beyond nucleotide + 3178 to the 3'-end of the cDNA clone ( Figure  3 ). This combined information extends the 3'-untranslated region and Figure 2 Schematic illustration of sequence heterogeneity found at the 5'-end of HuCe cDNA clones All diverge from the original, near full-length AMPD2 cDNA, HuPI 1 OB/16 [7] , at nucleotide + 28. Five of the HuCe clones (3B, 7A, 7B, iOA, 11) contain a 131 bp sequence (boxed) immediately adjacent to nucleotide + 28, the 3'-end of which is identical with nucleotides -175 to -181 in the HuPI 1 OB/16 cDNA. The suspected intervening sequence in the HuPI 1 OB/16 cDNA (nucleotides -174 to +27) is denoted above the inverted triangle and is bordered on its 5'-and 3'-ends by GT and AG dinucleotides (underlined) respectively. Two different patterns of 5'-end sequence are found adjacent to the 131 bp sequence in the HuCe cDNAs: clones 7A and 11 and clones 3B, 7B and lOA. The latter pattern is also found at the 5'-end of the HuCe 6A cDNA, although this clone is missing the internal 131 bp sequence found in the others. These two different sequences extend to the 5'-ends of each clone, except 7A, which has an anomalous sequence at its 5'-end (sequence not shown; see text). Taken together, these data suggest four different AMPD2 exons, three of which are variably expressed in different HuCe cDNA clones in the patternspresented to the right of their representative cDNA(s). The proposed exons, and their pattern of expression, are: one which is composed of a sequence 3' to nucleotide +28, and common to all clones (U); a second containing the internal 131 bp sequence ([1) that is either retained or excluded in these clones; a third (mD) and fourth (1) Figure 3 Evidence for heterogeneity at the 3'-end of human AMPD2 transcripts Alignment across the 3'-ends of the previously published HuPI 10B/16 cDNA (top), the HuCe 1 cDNA (middle), and the corresponding area of the AMPD2 gene (bottom). Inspection of the latter demonstrates a 149 bp intron (intron 17) between the nucleotide +2073/+2074 boundary of the published AMPD2 cDNA sequence [7] . Intron 17 is bordered by GT and AG dinucleotides (underlined) at its 5'-and 3'-ends respectively. A third overlapping genomic clone, labelled RPMI-2A, was not reported in the initial human library screening [7] . However, the 3'-end of this clone was subsequently found to contain the various divergent 5'-ends of the AMPD2 cDNA sequence. A physical map of the 3'-end of RPMI-2A is presented in Figure  4 (a) and shows the relative location of four exons. The 3'-most exon, labelled exon 3, contains the published sequence from nucleotides + 28 to + 158 [7] and is bordered by AG and GT dinucleotides at its 5'-and 3'-ends respectively (Figure 4b ). The next exon, labelled exon 2, is located 228 bp upstream and contains the 131 bp sequence found in five of the newly isolated AMPD2 cDNA clones (see above). Exon 2 is also bordered on its 5'-and 3'-ends by AG and GT dinucleotides respectively (Figure 4b) . Moreover, the 228 bp intervening sequence between exons 2 and 3 is identical with nucleotides -175 to + 27 in the published AMPD2 cDNA sequence, except for a 27 bp insertion at the nucleotide -39/ -40 boundary (see Figure 4b and [7] ). However, a re-examination of the original HuPl lOB/16 cDNA sequencing gel has revealed that these 27 nucleotides were inadvertently omitted from the original report. [7] and is found in all AMPD2 cDNA clones. plasmid was linearized at a Tfil restriction endonuclease site (GATTC; see Figure 4b ) and T7 RNA polymerase was used to generate a 157 base cRNA that included 153 bases complementary to the 5'-end of exon lB and four bases of pBS sequence at its 5'-end. Figure 5 illustrates the results of analyses using total cellular RNAs isolated from human adult liver (50 ,ctg) and RPE cells (20,tg) to protect these probes. Figure 5(a) shows multiple protected fragments of the exon IA probe ranging in size from 120-190 bases. Moreover, similar protection patterns are evident with adult liver and RPE cell RNAs. Figure 5 (b) reveals that while both sources of RNA predominantly protect the entire 153 bases of the AMPD2 sequence in the exon lB probe, patterns of partial protection differ. Adult liver RNA protects 45 and 47 base fragments and RPE cell RNA protects a 125 base fragment.
These combined RNase protection results complement those derived from the RT-PCR analyses. Protected fragment sizes of both probes indicate that AMPD2 mRNAs extend upstream across regions defined by the variable 5'-ends of exon 1A and exon lB cDNAs generated by RT-PCR analysis (see Figure 4b) . Taken together, these data establish that AMPD2 gene transcription initiates at multiple sites in both exons IA and lB.
RNase protection analyses of AMPD2 transcript expression Four cRNA probes were designed for use in additional RNase protection analyses to estimate alternative AMPD2 transcript abundances in human tissues. The first probe was designed from the 3'-end of the HuCe 1 cDNA and was used to examine heterogeneity at the 3'-end of AMPD2 transcripts. This probe extended 187 bases upstream to the middle of a PvuII restriction endonuclease site (nucleotide + 3077; see Figure 6 ). AMPD2 transcripts terminating at nucleotide + 3178 were expected to protect only 102 bases, i.e. nucleotides + 3077 to + 3178. Conversely, AMPD2 transcripts extending beyond this site were expected to fully protect the 187 bases of the AMPD2 sequence in this cRNA probe. Figure 6 shows that total cellular RNA isolated from HuCe predominantly protects a 102 base fragment. Nevertheless, detection of a 187 base fragment shows that a small percentage of AMPD2 transcripts in HuCe extend beyond nucleotide + 3178.
Three additional cRNA probes were designed to distinguish AMPD2 transcripts differing at, or near, their 5'-ends. The HuCe 11 (exon 1A-2 configuration), 3B (exon 1B-2 configuration) and 6A (exon 1B-3 configuration) cDNAs were chosen to represent different patterns of exon shuffling, as illustrated in Figure 2 . The first two of these three cRNA probes were composed of an antisense sequence located between an Fspl restriction endonuclease site in exon 2 (TGCGCA; see Figure 4b ) and the 5'-ends of either the HuCe 11 or 3B cDNA inserts. The third cRNA probe was composed of an antisense sequence located between a PvuII restriction endonuclease site in exon 3 (CAGCTG; see Figure 4b ) and the 5'-end of the HuCe 6A insert. The three AMPD2 cDNAs were digested with EcoRl (5'-end) and either Fspl (HuCe 11 and 3B) or PvuII (HuCe 6A), and fragments of the expected sizes were isolated and subcloned into the EcoRl and Smal (blunt-end) polycloning sites of pBS.
The HuCe 11 subclone was linearized with Smal, employing a unique site located in exon IA (CCCGGG; see Figure 4b ). The cRNA produced from this construct contained 93 bases of exon 2 and ended at the middle of the Smal site 67 bases into exon IA. AMPD2 transcripts containing the exon IA-2 configuration were expected to protect the entire 160 bases of the AMPD2 sequence in this cRNA probe. The HuCe 3B subclone was linearized with Ncol, employing a unique site located in exon lB utilizing the predicted downstream termination site would be expected to protect the entire 187 bases of the AMPD2 sequence in this probe, whereas those using the previously identified site at nucleotide +3178 [7] would be expected to protect only 102 bases. P, Undigested probe (full-length probe is 202 bases and includes 15 bases of polycloning and linker sequence); DP, digested probe (tRNA control); Br, 15 ,ug of HuCe (brain) total cellular RNA.
(CCATGG; see Figure 4b ). The cRNA probe produced from this construct also contained 93 bases of exon 2, but then extended 92 bases into exon lB where it ended at the 5'-overhang of the Ncol site. AMPD2 transcripts containing the exon IB-2 configuration were expected to fully protect the 185 bases of the AMPD2 sequence in this cRNA probe. The HuCe 6A subclone was linearized with EcoRl, employing the created site at the 5'-end of this clone. The cRNA probe produced from this construct, which was missing exon 2, contained 84 bases of exon 3 and 29 bases of exon lB. AMPD2 transcripts containing the exon IB-3 configuration were expected to fully protect the 113 bases of the AMPD2 sequence in this probe. Figure 7 shows the results of parallel RNase protection analyses using total cellular RNAs isolated from human liver (50,ug) and cerebellum (20 ,tg) to protect each cRNA probe.
From these data, it is apparent that AMPD2 gene expression is dramatically different in human liver and brain. Human liver predominantly contains the AMPD2 transcript with the exon IA-2 configuration (Figure 7a ) and relatively less with either the exon IB-2 (Figure 7b ) or exon IB-3 (Figure 7c) configurations, and relatively less transcript initiating in exon 1A.
DISCUSSION
A previous report from this laboratory represents the only available information on the human AMPD2 gene [7] . Data presented in this study clarify and extend knowledge of AMPD2 gene structure and its expression in human tissues. An intron has been identified in the original cDNA sequence and its location determined in the AMPD2 [7] ), the sizes of the three identified AMPD2 mRNAs may now be set at: 3755 nucleotides, exon IA-2 configuration; 3970 nucleotides, exon 1 B-2 configuration; and 3839 nucleotides, exon 1 B-3 configuration. These sizes are based on usage of 5'-most transcription-initiation sites in exons IA and 1 B and do not take into account the use of downstream initiation sites or the extension of the 3' untranslated sequence in alternative transcripts. Nevertheless, the addition of a poly(A)+ tail to these updated sequences closely approximates the 4 kb Northern blot estimation of AMPD2 transcript size [7] .
Molecular events leading to alternative AMPD2 transcript production may now be proposed. Based on its internal position and pattern of inclusion in mature transcripts, exon 2 appears to be subject to a cassette alternative splicing event [13] regulated by two tandem promoters. Notably, there are no apparent TATA or CAAT boxes in proximal sequence immediately upstream of either exon lA or lB (see Figure 4b) . One of the proposed functions of TATA boxes in higher eukaryotic promoters is to direct the formation of a stable pre-initiation complex with RNA polymerase [15] . Lack of TATA boxes in putative promoter regions of the AMPD2 gene may relate to the observation of multiple transcription-initiation sites in exons IA and lB. While neither putative promoter region appears to exhibit features typical of higher eukaryotic genes, functional regulatory elements are likely to be present in these sequences. Planned studies are aimed at examining these upstream regions for promoter activities, which may overlap owing to their close proximity. Regarding the possibility of two tandem promoters in the human AMPD2 gene, relative transcript abundance data presented in this study indicate that the putative exon lB promoter predominates in brain, whereas the putative exon IA promoter is stronger in liver. The AMPD2 gene is specific for AMPD isoform L, and a 760 amino acid polypeptide with a predicted molecular mass of 88.1 kDa had been proposed based on an identified 2280 bp open reading frame in the original HuPl lOB/16 cDNA [7] . However, it is now apparent that the first 27 nucleotides of the published open reading frame actually represented the 3'-terminal region of an intron. What impact does the corrected and additional sequence information presented in this study have on the predicted primary amino acid sequence of isoform L? Figure 8 shows three different predicted N-terminal sequences together with a 751 amino acid C-terminal core polypeptide, i.e. residues 10-760 of the published predicted amino acid sequence [7] .
AMPD2 mRNA containing the exon 1A-2 configuration extends the N-terminus of this isoform L variant by 47 residues, resulting in a 798 amino acid polypeptide with a predicted subunit molecular mass of 92.1 kDa. Most of this N-terminal extension results from an exon 2-encoded sequence, with the initiator methionine codon predicted to be near the 3'-end of exon IA (see Figure 4b ). AMPD2 mRNA containing the exon 1B-2 configuration encodes the largest isoform L variant and extends the N-terminus by 128 residues, i.e. an 879 amino acid polypeptide with a predicted subunit molecular mass of 100.7 kDa. AMPD2 mRNA containing the exon 1B-3 configuration extends the N-terminus of this isoform L variant by 53 amino acids and encodes an 804 amino acid polypeptide with a predicted subunit molecular mass of 92.9 kDa. Compared with the one encoded by AMPD2 mRNA containing the exon 1B-2 configuration, the predicted polypeptide encoded by this transcript is smaller. This is due not only to the lack of the exon 2 sequence, but also because a different exon lB open reading frame is employed.
The functional significance of N-terminal variability among the predicted isoform L variants is unknown. However, a computer-assisted examination of encoded N-terminal residues reveals that the extension encoded by the exon 1B-2 mRNA has several potential sites for post-translational modifications, including three sites for phosphorylation (two protein kinase C and one cyclic AMP-dependent) and one for the attachment of a glycosaminoglycan residue (see Figure 8) . Comparisons among the entire three predicted isoform L sequences indicate that cAMP-dependent phosphorylation and glycosaminoglycan attachment sites are unique to the N-terminal region encoded by exon 1B-2 mRNA. Potential post-translational events can also occur in the N-terminal region encoded by the two other alternative AMPD2 transcripts, but are not unique modifications relative to the rest of the predicted polypeptides. However, the N-terminal extension encoded by exon 1B-3 mRNA is prolinerich and contains three consensus SH3-binding motifs [16] .
Previous work has shown that the human AMPD2 gene and its encoded protein product, AMPD isoform L, are widely expressed in adult tissues and cells [3, 4, 7] . This study has identified alternative AMPD2 mRNAs and shown different patterns of their expression in liver and brain. Furthermore, alternative AMPD2 mRNAs are predicted to encode variant forms of isoform L, differing from each other in their extreme N-terminal regions. Additional studies will be required in order to determine the biological significance for this microdiversity in isoform L expression. 
